Metabolite of ellagitannins, urolithin A induces autophagy and inhibits metastasis in human sw620 colorectal cancer cells

Molecular Carcinogenesis

Volumn 57, Issue 2, 2018, Pages 193-200

  Zhao, Wenhua ^a   Shi, Fengqiang ^a   Guo, Zhikun ^a   Zhao, Jiaojie ^a   Song, Xueying ^a   Yang, Hua ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

autophagy; colorectal cancer; matrix metallo proteinases; metastasis; urolithin A

Indexed keywords

3 METHYLADENINE; ANTIMETASTATIC AGENT; AUTOPHAGY RELATED PROTEIN 5; BAFILOMYCIN; CASPASE 3; CHLOROQUINE; DNA; DRUG METABOLITE; ELLAGITANNIN; GELATINASE B; POLYPHENOL DERIVATIVE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UROLITHIN A; 3,8-DIHYDROXY-6H-DIBENZO(B,D)PYRAN-6-ONE; CASPASE; COUMARIN DERIVATIVE; TANNIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOLYSOSOME; AUTOPHAGY; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; METABOLITE; METASTASIS; METASTASIS INHIBITION; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; SW620 CELL LINE; CELL MOTION; COLORECTAL TUMOR; DRUG EFFECT; METABOLISM; TUMOR CELL LINE;

APOPTOSIS; AUTOPHAGY; CASPASES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; COUMARINS; HUMANS; HYDROLYZABLE TANNINS; MATRIX METALLOPROTEINASE 9; RNA, SMALL INTERFERING;

EID: 85040169221     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22746     Document Type: Article

References (53)

1. Zakraoui O, Marcinkiewicz C, Aloui Z, et al. Lebein, snake venom disintegrin, suppresses human colon cancer cells proliferation andtumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition ofVEGF expression. Mol Carcinog. 2017; 56:18–35.
2. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004; 96:1420–1425.
3. Ferraresi A, Phadngam S, Morani F, et al. Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulationof autophagy. Mol Carcinog. 2017; 56:1164–1181.
4. Jane EP, Premkumar DR, Sutera PA, et al. Survivin inhibitor YM155 induces mitochondrial dysfunction, autophagy, DNA damage andapoptosis in Bcl-xL silenced glioma cell lines. Mol Carcinog. 2017; 56:1251–1265.
5. Gewirtz DA. Cytoprotective and nonprotective autophagy in cancer therapy. Autophagy. 2013; 9:1263–1265.
6. Thorburn A, Thamm DH, Gustafson DL. Autophagy and cancer therapy. Mol Pharmacol. 2014; 85:830–838.
7. Ágata RT, Alicia B, Cecilia M, et al. The pepper's natural ingredient capsaicin induces autophagy blockage in prostate cancer cells. Oncotarget. 2015; 27:1–15.
8. Yu XF, Shi WN, Zhang YH, et al. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer. Sci Rep. 2017; 7:42226.
9. Su Z, Yang Z, Xu Y, et al. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer. 2015; 14:48.
10. Takeo Nitta YS, Ren X, Harada K, et al. Autophagy may promote carcinoma cell invasion and correlate with poor prognosis in cholangiocarcinoma. Int J Clin Exp Pathol. 2014; 7:4913–4921.
11. Yang MP, Zhao H, Guo L, et al. Autophagy-based survival prognosis in human colorectal carcinoma. Oncotarget. 2015; 9:7084–7103.
12. Babykutty S, S PP, J NR, et al. Nimbolide retards tumor cell migration, invasion, and angiogenesis by downregulating MMP-2/9expression via inhibiting ERK1/2 and reducing DNA-binding activity of NF-κB in colon cancer cells. Mol Carcinog. 2012; 51:475–490.
13. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006; 25:9–34.
14. Bendardaf R, Buhmeida A, Hilska M, et al. MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients. Cancer Invest. 2010; 28:38–43.
15. Carlos MP, Carol W, Arran KT, et al. Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer models. Br J Cancer. 2016; 114:905–916.
16. Tian L, Song Z, Shao W, et al. Curcumin represses mouse 3T3-L1 cell adipogenic differentiation via inhibiting miR-17-5p and stimulating the Wnt signalling pathway effector Tcf7l2. Cell Death Dis. 2017; 8:2559.
17. Haraguch T, Kayashima T, Okazaki Y, et al. Cecal succinate elevated by some dietary polyphenols may inhibit colon cancer cell proliferation and angiogenesis. J Agr Food Chem. 2014; 62:5589–5594.
18. Aichinger G, Beisl J, Marko D. Genistein and delphinidin antagonize the genotoxic effects of the mycotoxin alternariol in humancolon carcinoma cells. Mol Nutr Food Res. 2017; 61:1600462(1-10).
19. Khan N, Mukhtar H. Dietary agents for prevention and treatment of lung cancer. Cancer Lett. 2015; 359:155–164.
20. Trung LQ, Espinoza JL, An DT, et al. Resveratrol selectively induces apoptosis in malignant cells with the JAK2V617F mutation byinhibiting the JAK2 pathway. Mol Nutr Food Res. 2015; 59:2143–2154.
21. Tomás-Barberán FA, González-Sarrías A, García-Villalba R, et al. Urolithins, the rescue of “old” metabolites to understand a “new” concept: metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status. Mol Nutr Food Res. 2017; 61:1500901(1-35).
22. Kasimsetty SG, Bialonska D, Reddy MK, et al. Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. J Agr Food Chem. 2010; 58:2180–2187.
23. Landete JM. Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health. Food Res Int. 2011; 44:1150–1160.
24. Zhao WH, Wang YJ, Hao WJ, et al. Preparative isolation and purification of urolithins from the intestinal metabolites of pomegranate ellagitannins by high-speed counter-current chromatography. J Chromatogr B. 2015; 990:111–117.
25. Furlanetto V, Zagotto G, Pasquale R, et al. Ellagic acid and polyhydroxylated urolithins are potent catalytic inhibitors of human topoisomerase II: an in vitro study. J Agr Food Chem. 2012; 60:9162–9170.
26. Bialonska D, Kasimsetty SG, Khan SI, et al. Urolithins, intestinal microbial metabolites of Pomegranate ellagitannins, exhibit potent antioxidant activity in a cell-based assay. J Agr Food Chem. 2009; 57:10181–10186.
27. Larrosa M, Gonzalez-Sarrias A, Yanez-Gascon MJ, et al. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J Nutr Biochem. 2010; 21:717–725.
28. Piwowarski JP, Kiss AK, Granica S, et al. Urolithins, gut microbiota-derived metabolites of ellagitannins, inhibit LPS-induced inflammation in RAW 264.7 murine macrophages. Mol Nutr Food Res. 2015; 59:2168–2177.
29. Rodriguez J, Caille O, Ferreira D, et al. Pomegranate extract prevents skeletal muscle of mice against wasting induced by acute TNF-α injection. Mol Nutr Food Res. 2017; 61: https://doi.org/10.1002/mnfr.201600169
30. Giménez-Bastida JA, Truchado P, Larrosa M, et al. Urolithins, ellagitannin metabolites produced by colon microbiota, inhibit Quorum Sensing in Yersinia enterocolitica: phenotypic response and associated molecular changes. Food Chem. 2012; 32:1465–1474.
31. Kasimsetty SG, Bialonska D, Reddy MK, et al. Effects of pomegranate chemical constituents/intestinal microbial metabolites on CYP1B1 in 22Rv1 prostate cancer cells. J Agr Food Chem. 2009; 57:10636–10644.
32. Kang I, Kim Y, Tomás-Barberán FA, et al. Urolithin A, C, and D, but not iso-urolithin A and urolithin B, attenuate triglyceride accumulation in human cultures of adipocytes and hepatocytes. Mol Nutr Food Res. 2016; 60:1129–1138.
33. Gonzalez-Sarrias A, Espin JC, Tomas-Barberan FA, et al. Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins. Mol Nutr Food Res. 2009; 53:686–698.
34. González-Sarrías A, Núñez-Sánchez MÁ, Tomé-Carneiro J, et al. Comprehensive characterization of the effects of ellagic acid and urolithins on colorectal cancerand key-associated molecular hallmarks: microRNA cell specific induction of CDKN1A (p21) as acommon mechanism involved. Mol Nutr Food Res. 2016; 60:701–716.
35. Qiu Z, Zhou B, Jin L, et al. In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells. Food Chem Toxicol. 2013; 59:428–437.
36. Adams LS, Zhang Y, Seeram NP, et al. Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Prev Res. 2010; 3:108–113.
37. Olennikov DN, Kashchenko NI, Chirikova NK. In vitro bioaccessibility, human gut microbiota metabolites and hepatoprotective potential of chebulic ellagitannins: a case of padma hepaten formulation. Nutrients. 2015; 13:8456–8477.
38. Fantini M, Benvenuto M, Masuelli L, et al. In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment. Int J Mol Sci. 2015; 16:9236–9282.
39. Lall RK, Syed DN, Adhami VM, et al. Dietary polyphenols in prevention and treatment of prostate cancer. Int J Mol Sci. 2015; 16:3350–3376.
40. Sancho M, Mach N. Effects of wine polyphenols on cancer prevention. Nutr Hosp. 2014; 31:535–551.
41. Lee WS, Yun JW, Jung JH, et al. Polyphenols isolated from allium cepa L. induces apoptosis by induction of p53 and suppression of bcl-2 through inhibiting PI3K/Akt signaling pathway in AGS human cancer cells. J Cancer Prev. 2014; 19:14–22.
42. Mukherjee S, Ghosh S, Choudhury S, et al. Pomegranate reverses methotrexate-induced oxidative stress and apoptosis in hepatocytes by modulating Nrf2-NF-kappaB pathways. J Nutr Biochem. 2013; 24:2040–2050.
43. Zhao X, Pang L, Li J, et al. Apoptosis inducing effects of Kuding tea polyphenols in human buccal squamous cell carcinoma cell line BcaCD885. Nutrients. 2014; 6:3084–3100.
44. Halder B, Bhattacharya U, Mukhopadhyay S, et al. Molecular mechanism of black tea polyphenols induced apoptosis in human skin cancer cells: involvement of Bax translocation and mitochondria mediated death cascade. Carcinogenesis. 2008; 29:129–138.
45. Thakur VS, Gupta K, Gupta S. Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases. Carcinogenesis. 2012; 33:377–384.
46. Zhao WH, Wang YJ, Hao WJ, et al. In vitro inhibition of fatty acid synthase by 1,2,3,4,6-penta-O-galloyl-beta-D-glucose plays a vital role in anti-tumour activity. BBRC. 2014; 445:346–351.
47. Cho H, Jung H, Lee H, et al. Chemopreventive activity of ellagitannins and their derivatives from black raspberry seeds on HT-29 colon cancer cells. Food Func. 2015; 6:1675–1683.
48. Gonzalez-Sarrias A, Tome-Carneiro J, Bellesia A, et al. The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells. Food Funct. 2015; 6:1460–1469.
49. Ito S, Koshikawa N, Mochizuki S, et al. 3-Methyladenine suppresses cell migration and invasion of HT1080 fibrosarcoma cells through inhibiting phosphoinositide 3-kinases independently of autophagy inhibition. Int J Oncol. 2007; 31:261–268.
50. Liao CC, Ho MY, Liang SM, et al. Recombinant protein rVP1 upregulates BECN1-independent autophagy, MAPK1/3 phosphorylation and MMP9 activity via WIPI1/WIPI2 to promote macrophage migration. Autophagy. 2015; 9:5–19.
51. Tyagi N, Vacek JC, Givvimani S, et al. Cardiac specific deletion of N-methyl-d-aspartate receptor 1 ameliorates mtMMP-9 mediated autophagy/mitophagy in hyperhomocysteinemia. J Recept Signal Tr R. 2010; 30:78–87.
52. Dong YH, Yin ST, Jiang C, et al. Involvement of autophagy induction in penta-1,2,3,4,6-O-galloyl-β-D-glucose-induced senescence-like growth arrest in human cancer cells. Autophagy. 2014; 10:296–310.
53. Filomeni G, Desideri E, Cardaci S, et al. Carcinoma cells activate AMP-activated protein kinase-dependent autophagy as survival response to kaempferol-mediated energetic impairment. Autophagy. 2014; 6:202–216.